| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
JPAG - PAST MEETINGS
RETURN TO MEETINGS
Thursday 15th May 2025
Stability VIII
Royal Society of Chemistry, London
Continuing our successful series of stability meetings, this 8th event is essential for anyone concerned with the management and assessment of drug stability. This year we are partnering with Lhasa Limited to bring you a group of expert speakers from industry and academia who will provide background information and case studies on a variety of new approaches to stability testing and predictive stability tools.
The latest updates to the ICH Q1 guidance will be shared by members of the EFPIA group (European Federation of Pharmaceutical Industries and Associations). Hear about particular stability challenges in testing, dissolution slow down, examine the assumptions of accelerated stability models and learn from our expert speakers on frameworks and practical solutions. In addition, the presenters will offer thoughts on the science and risk based stability challenges to shelf-life setting. In silico tools such as ASAP and Zeneth are coming to the fore in predictive stability work. Experts will present case studies using these, and other tools, and are open for discussion throughout the symposium.
Posters are invited from industry and academia on any stability topics to facilitate additional interaction between attendees and speakers.
Speakers:
Barton Dear - BMS
Dr Carolyn Gordon - AstraZeneca
Roy Jamieson - OkerPharma Consultancy AB
John Kulig - BMS
Dr Andrew Lennard - Amgen
Dr Gemma Packer - Lhasa Limited
Dr Andrew Postles - Medik8
Sara Ryan - AstraZeneca
Luke Scrivens - AstraZeneca
Dr Gabriela Silveira - Lhasa Limited
Stability VIII
Royal Society of Chemistry, London
Continuing our successful series of stability meetings, this 8th event is essential for anyone concerned with the management and assessment of drug stability. This year we are partnering with Lhasa Limited to bring you a group of expert speakers from industry and academia who will provide background information and case studies on a variety of new approaches to stability testing and predictive stability tools.
The latest updates to the ICH Q1 guidance will be shared by members of the EFPIA group (European Federation of Pharmaceutical Industries and Associations). Hear about particular stability challenges in testing, dissolution slow down, examine the assumptions of accelerated stability models and learn from our expert speakers on frameworks and practical solutions. In addition, the presenters will offer thoughts on the science and risk based stability challenges to shelf-life setting. In silico tools such as ASAP and Zeneth are coming to the fore in predictive stability work. Experts will present case studies using these, and other tools, and are open for discussion throughout the symposium.
Posters are invited from industry and academia on any stability topics to facilitate additional interaction between attendees and speakers.
Speakers:
Barton Dear - BMS
Dr Carolyn Gordon - AstraZeneca
Roy Jamieson - OkerPharma Consultancy AB
John Kulig - BMS
Dr Andrew Lennard - Amgen
Dr Gemma Packer - Lhasa Limited
Dr Andrew Postles - Medik8
Sara Ryan - AstraZeneca
Luke Scrivens - AstraZeneca
Dr Gabriela Silveira - Lhasa Limited
RETURN TO MEETINGS
WANT TO SEE MORE?
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
PAST MEETINGS
Symposium - October 2011
Delegates at a symposium held at the Royal Pharmaceutical Society
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| Joint Pharmaceutical Analysis Group 2025 Website © and by Delta Consultancy Services |
|